Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Hamstra

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 5, 2012
The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapyHanan Amro, Daniel A Hamstra, Daniel L Mcshan, et al.
American Journal of Clinical Oncology|February 4, 2014
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation TherapyJeffrey M Vainshtein, Matthew Schipper, Sean Vance, et al.
Cancer Research|August 4, 2006
Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imagingDaniel A Hamstra, Mahaveer S Bhojani, Laura B Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapyKuei C Lee, Daniel A Hamstra, Mahaveer S Bhojani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculatureJames D Murphy, Aaron C Spalding, Yash R Somnay, et al.
Translational Oncology|December 2, 2008
Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neckDaniel A Hamstra, Kuei C Lee, Bradford A Moffat, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapyMark Shilkrut, P William McLaughlin, Gregory S Merrick, et al.
JAMA Network Open|March 11, 2025
Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing RadiotherapyMichael R Folkert, Ryoko Sato, James B Yu, et al.
BJU International|April 26, 2020
Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of lifeZachary A Seymour, Daniel A Hamstra, Stephanie Daignault-Newton, et al.
Radiation Oncology (London, England)|November 27, 2014
Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapyCorey C Foster, William C Jackson, Benjamin C Foster, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|May 5, 2012
The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapyHanan Amro, Daniel A Hamstra, Daniel L Mcshan, et al.
American Journal of Clinical Oncology|February 4, 2014
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation TherapyJeffrey M Vainshtein, Matthew Schipper, Sean Vance, et al.
Cancer Research|August 4, 2006
Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imagingDaniel A Hamstra, Mahaveer S Bhojani, Laura B Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapyKuei C Lee, Daniel A Hamstra, Mahaveer S Bhojani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculatureJames D Murphy, Aaron C Spalding, Yash R Somnay, et al.
Translational Oncology|December 2, 2008
Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neckDaniel A Hamstra, Kuei C Lee, Bradford A Moffat, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapyMark Shilkrut, P William McLaughlin, Gregory S Merrick, et al.
JAMA Network Open|March 11, 2025
Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing RadiotherapyMichael R Folkert, Ryoko Sato, James B Yu, et al.
BJU International|April 26, 2020
Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of lifeZachary A Seymour, Daniel A Hamstra, Stephanie Daignault-Newton, et al.
Radiation Oncology (London, England)|November 27, 2014
Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapyCorey C Foster, William C Jackson, Benjamin C Foster, et al.
Pageof 13